Imatinib Denk 100 mg
Imatinib Denk 400 mg


  • Guideline-recommended for the treatment of chronic myeloid leukemia (CML).
  • Easy to take (orally, once daily with a meal and a large glass of water).
  • May be dispersed in fluid if patient has swallowing problems.

Proven bioequivalence

Imatinib Denk 100 mg in comparison with the original product: